Adaptive dosing and platinum–DNA adduct formation in children receiving high-dose carboplatin for the treatment of solid tumours

類似資料

• Platinum-DNA adduct formation in leucocytes of children in relation to pharmacokinetics after cisplatin and carboplatin therapy.
  著者:: Peng, B., 等
  出版事項: (1997)
• Population pharmacokinetics of carboplatin, etoposide and melphalan in children: a re‐evaluation of paediatric dosing formulas for carboplatin in patients with normal or mild impairment of renal function
  著者:: Duong, J.K., 等
  出版事項: (2018)
• Estimation of renal function and its potential impact on carboplatin dosing in children with cancer
  著者:: Chinnaswamy, G, 等
  出版事項: (2008)
• Pharmacokinetically guided dosing of carboplatin and etoposide during peritoneal dialysis and haemodialysis.
  著者:: English, M. W., 等
  出版事項: (1996)
• Pharmacokinetics and metabolism of 13-cis-retinoic acid (isotretinoin) in children with high-risk neuroblastoma – a study of the United Kingdom Children's Cancer Study Group
  著者:: Veal, G J, 等
  出版事項: (2007)